Company intelligence
Regenosca SA
Surgical tissue repair
About Regenosca SA
At Regenosca, we’re pioneering the future of regenerative medicine with a breakthrough platform that enables the body to heal itself—without synthetic implants or tissue grafts. Our 100% engineered, natural collagen scaffolds guide perfect tissue regeneration, offering a safer and more effective alternative to traditional treatments. With 100% success in urethra reconstruction—our initial indication in urology—demonstrated in a first-in-human trial (sustained at two-year follow-up), we’re proving the potential of our technology to transform tissue restoration across multiple medical fields. Our goal? To make tissue regeneration a reality for patients worldwide, through collaborations with clinicians, researchers, and industry partners. Join us in shaping the future of regenerative medicine—where technology meets the body’s innate healing power.
Verified activity
Signals from Regenosca SA
3 published signals
Research & Knowledge
Regenosca SA published the first clinical data for its TissueSpan implant in BMC Urology, marking the first-in-human safety and feasibility study for augmentation urethroplasty.
Reported by Eva-Maria Balet
Presence & Recognition
Regenosca SA participated in the panel discussion titled Cracking the Hospital Market: What It Takes to Get My Medical Innovation Adopted featuring Matthias Bryner, Prof. Dr. Michael Hirschmann, and Jannis Schönleber.
Reported by Eva-Maria Balet
Presence & Recognition
Regenosca SA attended the MedTech Innovation Event in Biel.
Reported by Eva-Maria Balet